cirmtuzumab
Cirmtuzumab is a drug used to treat Chronic Lymphocytic Leukemia and Metastatic Castration-resistant Prostate Cancer. Cirmtuzumab is being actively studied in 2 studies and prior, has been studied in 2.
Top Sponsors | Top Sites | Top Investigators |
---|---|---|
University of California, San Diego | UC San Diego Moores Cancer Center | Benjamin Heyman |
Thomas Kipps | UCSD Koman Family Outpatient Pavilion | Catriona Jamieson |
UCSD Moores Cancer Center | Rana Mckay |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
U
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Cirmtuzumab
- La Jolla, CaliforniaUniversity of California San Diego
2021-12-15
Dec 15, 2021U
Recruiting
- Chronic Lymphocytic Leukemia
- Cirmtuzumab
- Venetoclax
- San Diego, CaliforniaUCSD Koman Family Outpatient Pavilion
2021-11-24
Nov 24, 2021T
Completed
- Chronic Lymphocytic Leukemia
- cirmtuzumab
- La Jolla, CaliforniaUCSD Moores Cancer Center
2020-07-29
Jul 29, 2020U
Completed
- Chronic Lymphocytic Leukemia
- cirmtuzumab
- La Jolla, CaliforniaUC San Diego Moores Cancer Center
2019-03-18
Mar 18, 2019